According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
A team from the Wistar Institute has demonstrated the role of Parkin—a protein implicated in Parkinson's disease—in the ...
BOSTON - A new study finds Parkinson's disease may begin in the gut. Scientists have been interested in this possible link for some time.
L-dopa is a chemical which is converted to dopamine in our body and so act as anti-Parkinson’s drugs, according to the Ministry of Science & Technology. Advt It helps in compensating the ...
A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson's disease ...
People with a history of upper gastrointestinal (GI) damage have a 76% higher risk of developing Parkinson’s disease.
Over a mean follow-up of 14.9 years, Parkinson's diagnoses emerged for 52 patients (2.2%) with upper GI mucosal damage and 48 ...
Research in cell cultures and mice demonstrates an antidepressant called vortioxetine may be effective in combating glioblastomas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback